New research at Columbia University Mailman School of Public Health examined changes in binge drinking after the implementation of recreational cannabis laws.
FDA Approves New Frontline Regimen for Aggressive ALL
The FDA granted accelerated approval to ponatinib (Iclusig) in combination with chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in previously untreated adults, the